98 related articles for article (PubMed ID: 24968850)
1. [Diagnostic values of salivary versus and plasma microRNA-21 for early esophageal cancer].
Ye M; Ye P; Zhang W; Rao J; Xie Z
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jun; 34(6):885-9. PubMed ID: 24968850
[TBL] [Abstract][Full Text] [Related]
2. Salivary microRNAs as promising biomarkers for detection of esophageal cancer.
Xie Z; Chen G; Zhang X; Li D; Huang J; Yang C; Zhang P; Qin Y; Duan Y; Gong B; Li Z
PLoS One; 2013; 8(4):e57502. PubMed ID: 23560033
[TBL] [Abstract][Full Text] [Related]
3. Saliva supernatant miR-21: a novel potential biomarker for esophageal cancer detection.
Xie ZJ; Chen G; Zhang XC; Li DF; Huang J; Li ZJ
Asian Pac J Cancer Prev; 2012; 13(12):6145-9. PubMed ID: 23464420
[TBL] [Abstract][Full Text] [Related]
4. Plasma MicroRNA-34a as a Potential Biomarker for Early Diagnosis of Esophageal Cancer.
Lin Y; Lin Z; Fang Z; Li H; Zhi X; Zhang Z
Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710448
[TBL] [Abstract][Full Text] [Related]
5. Circulating miR-155 expression in plasma: a potential biomarker for early diagnosis of esophageal cancer in humans.
Liu R; Liao J; Yang M; Shi Y; Peng Y; Wang Y; Pan E; Guo W; Pu Y; Yin L
J Toxicol Environ Health A; 2012; 75(18):1154-62. PubMed ID: 22891887
[TBL] [Abstract][Full Text] [Related]
6. Serum miR-1297: a promising diagnostic biomarker in esophageal squamous cell carcinoma.
Wang C; Li Q; Liu F; Chen X; Nesa EU; Guan S; Liu B; Han L; Tan B; Wang D; Chen P; Liu X; Zhang H; Sun Y; Cheng Y
Biomarkers; 2016 Sep; 21(6):517-22. PubMed ID: 27152453
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY
J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223
[TBL] [Abstract][Full Text] [Related]
8. Plasma and saliva miR-21 expression in colorectal cancer patients.
Sazanov AA; Kiselyova EV; Zakharenko AA; Romanov MN; Zaraysky MI
J Appl Genet; 2017 May; 58(2):231-237. PubMed ID: 27910062
[TBL] [Abstract][Full Text] [Related]
9. Serum microRNA-218 is a potential biomarker for esophageal cancer.
Jiang Z; Song Q; Yang S; Zeng R; Li X; Jiang C; Ding W; Zhang J; Zheng Y
Cancer Biomark; 2015; 15(4):381-9. PubMed ID: 25812647
[TBL] [Abstract][Full Text] [Related]
10. Plasma microRNA might as a potential biomarker for hepatocellular carcinoma and chronic liver disease screening.
Jiang L; Li X; Cheng Q; Zhang BH
Tumour Biol; 2015 Sep; 36(9):7167-74. PubMed ID: 25894380
[TBL] [Abstract][Full Text] [Related]
11. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
[TBL] [Abstract][Full Text] [Related]
12. Potential diagnostic implications of miR-144 overexpression in human oesophageal cancer.
Sharma P; Saraya A; Sharma R
Indian J Med Res; 2016 May; 143(Supplement):S91-S103. PubMed ID: 27748283
[TBL] [Abstract][Full Text] [Related]
13. Salivary microRNAs show potential as a noninvasive biomarker for detecting resectable pancreatic cancer.
Xie Z; Yin X; Gong B; Nie W; Wu B; Zhang X; Huang J; Zhang P; Zhou Z; Li Z
Cancer Prev Res (Phila); 2015 Feb; 8(2):165-73. PubMed ID: 25538087
[TBL] [Abstract][Full Text] [Related]
14. Early Detection of Lung Cancer in Serum by a Panel of MicroRNA Biomarkers.
Wang P; Yang D; Zhang H; Wei X; Ma T; Cheng Z; Hong Q; Hu J; Zhuo H; Song Y; Jia C; Jing F; Jin Q; Bai C; Mao H; Zhao J
Clin Lung Cancer; 2015 Jul; 16(4):313-9.e1. PubMed ID: 25639977
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA biomarkers in whole blood for detection of pancreatic cancer.
Schultz NA; Dehlendorff C; Jensen BV; Bjerregaard JK; Nielsen KR; Bojesen SE; Calatayud D; Nielsen SE; Yilmaz M; Holländer NH; Andersen KK; Johansen JS
JAMA; 2014 Jan 22-29; 311(4):392-404. PubMed ID: 24449318
[TBL] [Abstract][Full Text] [Related]
16. Salivary MicroRNA in Pancreatic Cancer Patients.
Humeau M; Vignolle-Vidoni A; Sicard F; Martins F; Bournet B; Buscail L; Torrisani J; Cordelier P
PLoS One; 2015; 10(6):e0130996. PubMed ID: 26121640
[TBL] [Abstract][Full Text] [Related]
17. miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinoma.
Alemar B; Izetti P; Gregório C; Macedo GS; Castro MA; Osvaldt AB; Matte U; Ashton-Prolla P
Pancreas; 2016 Jan; 45(1):84-92. PubMed ID: 26262588
[TBL] [Abstract][Full Text] [Related]
18. [miRNA-144 in the saliva is a genetic marker for early diagnosis of esophageal cancer].
Wu W; Hou W; Wu Z; Wang Y; Yi Y; Lin W
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Dec; 33(12):1783-6. PubMed ID: 24369245
[TBL] [Abstract][Full Text] [Related]
19. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
[TBL] [Abstract][Full Text] [Related]
20. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
